In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Synopsys' current price at $450.46 is significantly below its PERT-weighted fair value of $989.27, indicating potential undervaluation amid mixed valuation signals and a high downside risk (86.1%). Financial health reflects fair liquidity but weak profitability and leverage concerns, contributing to valuation volatility (54.14% coefficient of variation). Monte Carlo analysis shows wide outcome dispersion ($125.53–$845.20), underscoring elevated uncertainty despite upside potential.